Boston Scientific SVP exercises 838 stock units

Boston Scientific (BSX) senior vice president Emily Woodworth reported equity compensation activity involving restricted stock units and common stock.

Rhea-AI Filing Summary

Boston Scientific (BSX) senior vice president Emily Woodworth reported equity compensation activity involving restricted stock units and common stock. On March 1, 2026, she exercised or converted 838 restricted stock units, which represent a commitment to issue one share of common stock for each unit.

The same day, she acquired 838 shares of Boston Scientific common stock through this derivative exercise. Also on March 1, 372 shares of common stock were disposed of at $76.85 per share in a transaction classified as payment of tax liability by delivering securities. After these transactions, she directly owned 1,676 restricted stock units and 2,859 common shares.

Insider Trade Summary

838 shares exercised/converted

Exercise 3 txns

Insider Woodworth Emily

Role SVP, Global Controller and CAO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	838	$0.00	$0.00
Exercise	Common Stock	838	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	372	$76.85	$29K

Holdings After Transaction: Restricted Stock Units — 1,676 contracts (Direct); Common Stock — 2,859 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. F2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Boston Scientific (BSX) executive Emily Woodworth report on this Form 4?

Emily Woodworth reported equity compensation activity on March 1, 2026. She exercised 838 restricted stock units into common shares and used 372 shares to satisfy tax obligations, updating her direct holdings in both units and stock.

How many restricted stock units did Emily Woodworth exercise at Boston Scientific (BSX)?

She exercised or converted 838 restricted stock units on March 1, 2026. Each restricted stock unit represents the company’s commitment to issue one share of Boston Scientific common stock, increasing her directly held common share balance reported after the transaction.

How many Boston Scientific (BSX) shares were used to cover taxes in this filing?

A total of 372 shares of Boston Scientific common stock were disposed of at $76.85 per share. The transaction is classified as a payment of tax liability by delivering securities, rather than an open-market purchase or sale.

What are Emily Woodworth’s Boston Scientific (BSX) holdings after these transactions?

After the March 1, 2026 activity, she directly held 1,676 restricted stock units and 2,859 shares of Boston Scientific common stock. These balances reflect the reported exercises and the shares delivered to satisfy tax obligations.

Does this Boston Scientific (BSX) Form 4 show a tax-withholding transaction?

Yes. The filing reports a transaction coded “F” for 372 common shares at $76.85 per share. This code indicates payment of an exercise price or tax liability by delivering securities rather than a typical market sale transaction.

How do restricted stock units work in this Boston Scientific (BSX) filing?

The filing notes each restricted stock unit represents a commitment to issue one share of Boston Scientific common stock. Shares of common stock are issued to the reporting person in four equal annual installments beginning March 1, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 05:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Woodworth Emily

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MA 01752-1234

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Global Controller and CAO

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		M		838	A	$0.0000(1)	3,231	D
Common Stock	03/01/2026		F		372	D	$76.85	2,859	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/01/2026		M			838	(2)	03/01/2028(2)	Common Stock	838	$0.0000	1,676	D

Explanation of Responses:

1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on March 1, 2025, the first anniversary of the date of grant.

	/s/ Susan Thompson, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.